Keros Therapeutics
KROS
$57.76
Share price
0.07%
Change (1 day)
25.37%
Change (1 year)
Categories
Keros Therapeutics (KROS) - P/B ratio
P/B ratio as of May 2024 : 6.27
According to Keros Therapeutics's latest financial reports the company has a price-to-book ratio of 6.27.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Keros Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.59 | -24.79% |
| 2022-12-31 | 4.77 | -15.32% |
| 2021-12-31 | 5.63 | -9.88% |
| 2020-12-31 | 6.25 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.81 | -55.20% | 🇺🇸 USA |